# c-LEcta

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/c-lecta

- Industry: Biotechnology
- Headquarters: Leipzig, Germany
- Website: www.c-lecta.com
- Latest round: Series C (Apr 8, 2008)
- Investors on record: 2

## About

c-LEcta GmbH is a biotechnology company focused on the development, production, and distribution of enzyme products primarily for the food and pharmaceutical sectors.Founded in 2004 and headquartered in Leipzig, Germany, c-LEcta GmbH specializes in enzyme production and distribution. The company has secured a total of 6 funding deals, with the most recent being a TRADE SALE in February 2022, where Kerry Group plc acquired a 92% stake for EUR 137 million. The CEO and Founder, Marc Struhalla, has had experience in the biotech sector prior to establishing c-LEcta.c-LEcta GmbH specializes in the development, production, and distribution of enzyme products tailored primarily for the food and pharmaceutical industries. Their core offerings include proprietary enzyme solutions like DENARASE®, utilized in pharmaceutical applications and food sector enzymes that support efficient production of food components and additives. The company's technology platform, ENESYZ, facilitates enzyme customization for over 400 global clients, addressing diverse manufacturing needs across Europe, North America, and Asia.c-LEcta GmbH generates revenue through B2B sales of enzyme products such as DENARASE® and NUCLENASE®. Revenue is structured around direct sales to manufacturers seeking efficient biocatalytic solutions, with contracts typically based on order volume. This business model supports ongoing partnerships and collaborations in enzyme development and application.Following the TRADE SALE on February 15, 2022, c-LEcta GmbH plans to leverage the EUR 137 million acquisition by Kerry Group plc to enhance their product offerings and expand into new markets. The company aims to develop additional enzyme products targeting both food and pharmaceutical sectors by 2023, while also focusing on geographic expansion into untapped markets in Asia and North America.

## Funding rounds

- Series C, Apr 8, 2008 — SHS Gesellschaft fur Beteiligungsmanagement, High-Tech Gruenderfonds

## Investors

- SHS Gesellschaft fur Beteiligungsmanagement (https://capitalatlas.ai/funds/shs-gesellschaft-fur-beteiligungsmanagement) — Series C
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Series C